Abstract:Objective To explore the effects of dialysate calcium concentrations (DCC)on risks of adverse reactions occurred in maintenance hemodialysis patients during dialysis. Methods The subjects were end-stage renal disease (ESRD)patients in stable condition who were treated with maintenance dialysis in the First Affiliated Hospital,Zhejiang University from June to October 2016. According to the DCC,the patients were randomly divided into 3 groups,the 1.25 mmol/L group,the 1.35 mmol/L group,and the 1.50 mmol/L group;the observation time was 12 weeks. The urea clearance index Kt/V,urea reduction rate (URR),mean arterial pressure before and after dialysis,the serum calcium,serum phosphorus,intact parathyroid hormone (iPTH),and alkaline phosphatase (ALP)levels before and after dialysis,and the incidence of muscle spasm,nausea and vomiting,headache,chest tightness,and arrhythmia in hemodialysis patients in the 3 groups were compared. Results A total of 273 patients entered the study,including 159 males and 114 females with ages from 25 to 83 years and average age of (52 ± 9)years. Each of the 1.25 mmol/L,1.35 mmol/L,and 1. 50 mmol/L groups comprised 91 patients. The differences of baseline data in patients in the 3 groups were not statistically significant (P＞0.05). After 12 weeks of hemodialysis,the differences of Kt/V and URR in patients in the 3 groups were not statistically significant (all P＞0.05);the differences of the mean arterial pressures in patients in the 1.25 and 1.35 mmol/L groups [(102 ± 9)and (103 ±11)mmHg,respectively]were not statistically significant (all P ＞0.0.5);the mean arterial pressure in the patients in the 1.50 mmol/L group was higher than that before hemodialysis [(120 ± 12) mmHg vs.(103 ± 9)mmHg,P＜0.01]and was higher markedly than that in 1.25 and 1.35 mmol/L groups (all P＜0.01);the serum calcium level in patients in the 1.25 mmol/L group was lower than that before hemodialysis [(1.94 ± 0.31)mmol/L vs.(2.24 ± 0.18)mmol/L,P＜0.01];the serum calcium level in the patients in the 1.50 mmol/L group was higher than that before hemodialysis [(2.54 ± 0.18) mmol/L vs.(2.24 ± 0.17)mmol/L,P＜0.01];the iPTH and ALP levels in patients in the 1.25 mmol/L group were higher than those before hemodialysis [(356 ± 68)U vs.(291 ± 49)U,(443 ± 45)U vs. (343 ± 58)U,all P ＜0.01]. During dialysis,the incidence of muscle spasm in patients in the 1.25 mmol/L group was higher than that in the 1.35 mmol/L and 1.50 mmol/L groups [14.28% (13/91)vs. 5.49% (5/91)and 4.39% (4/91),all P ＜0.05];the incidence of headache in patients in the 1.50 mmol/L group was higher than that in the 1.25 mmol/L and 1.35 mmol/L groups [14.28% (13/91)vs. 3.30% (3/91)and 5.49% (5/91),P ＝0.01 and P ＜0.05]. The differences in incidences of chest tightness,arrhythmia,nausea and vomiting were not statistically significant (all P＞0.05). Conclusion The dialysate with calcium concentration of 1.35 mmol/L may reduce the incidence of muscle spasm,does not increase the incidence of hypertension and headache,and effectively reduce the risk of adverse reactions in maintenance hemodialysis patients,while ensuring the adequacy of dialysis.

Effect of central dialysis fluid delivery system on markers of inflammation in hemodialysis patients

The Design and Clinical Application of a New Type of Disposable Heparin Free Dialysis Tube

Upgrade of dialysate quality improves the microinflammation in maintenance haemodialysis patients

Diabetic Patients Could Do As Well As Non-Diabetic Patients Without Inflammation on Peritoneal Dialysis

Comparison of Dietary Inflammatory Index Scores with Inflammatory and Anthropometric Metrics in Individuals Receiving Maintenance Hemodialysis

Randomized Controlled Trial of Dialysate Calcium Concentrations on Risks of Adverse Reactions in Hemodialysis Patients During Dialysis

China Collaborative Study on Dialysis: a Multi-Centers Cohort Study on Cardiovascular Diseases in Patients on Maintenance Dialysis

Acute Effects of Hemodiafiltration Versus Conventional Hemodialysis on Endothelial Function and Inflammation: A Randomized Crossover Study.

A Clinical study on the Effect of Peritoneal Dialysis and Hemodialysis on the Microinflammatory State and Quality of Life in Patients with Chronic Renal Failure

Inflammatory index is a promising biomarker for maintenance hemodialysis patients with cardiovascular disease

Diagnostic Value of Systemic Inflammatory Response Index for Catheter-Related Bloodstream Infection in Patients Undergoing Haemodialysis

Acute Effect of One Session of Hemodiafiltration with Endogenous Reinfusion on Uremic Toxins and Inflammatory Mediators.

Effects of Different Dialysis Methods on Calcium and Phosphorus Metabolism and Inflammatory Factor Levels in Patients with End-Stage Renal Disease

The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patients

The Effects of Oral Vitamin Con Microinflammatory State in Hemodialysis Patients

High-flux Hemodialysis Efficiently Removes Β_2-Microglobin and Improves Inflammation Status in Maintain Hemodialysis Patients

To Explore the Application of PDCA in Hemodialysis Center and Its Effect on the Maintenance of Internal Fistula

Effect of hemodialysis combined with blood perfusion and comprehensive nursing intervention on the levels of interleukin-6, C-reactive protein and β2-microglobulin in patients with diabetic nephropathy

Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients

Effects of a medium cut‐off dialyzer on inflammation and cardiac and vascular function in hemodialysis patients with heart failure

Effects of Microbiological Improvement of Dialysate on Nutritional Status and Inflammatory Parameters in Maintenance Hemodialysis Patients